E2F3
Transcription factor E2F3
Also known as: E2F3_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- O00716
- Gene
- E2F3
- Ensembl
- ENSG00000112242
- Chromosome
- 6
- Canonical length
- 465 aa
- Protein class
- Cancer-related genes, Predicted intracellular proteins, Transcription factors
- Subcellular location
- Nucleoplasm
OverviewNCBI Gene
This gene encodes a member of a small family of transcription factors that function through binding of DP interaction partner proteins. The encoded protein recognizes a specific sequence motif in DNA and interacts directly with the retinoblastoma protein (pRB) to regulate the expression of genes involved in the cell cycle. Altered copy number and activity of this gene have been observed in a number of human cancers. There are pseudogenes for this gene on chromosomes 2 and 17. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Mar 2013]
Canonical amino-acid sequenceUniProt
465 residues, UniProt reviewed canonical sequence.
>O00716|E2F3
1 MRKGIQPALE QYLVTAGGGE GAAVVAAAAA ASMDKRALLA SPGFAAAAAA AAAPGAYIQI
61 LTTNTSTTSC SSSLQSGAVA AGPLLPSAPG AEQTAGSLLY TTPHGPSSRA GLLQQPPALG
121 RGGSGGGGGP PAKRRLELGE SGHQYLSDGL KTPKGKGRAA LRSPDSPKTP KSPSEKTRYD
181 TSLGLLTKKF IQLLSQSPDG VLDLNKAAEV LKVQKRRIYD ITNVLEGIHL IKKKSKNNVQ
241 WMGCSLSEDG GMLAQCQGLS KEVTELSQEE KKLDELIQSC TLDLKLLTED SENQRLAYVT
301 YQDIRKISGL KDQTVIVVKA PPETRLEVPD SIESLQIHLA STQGPIEVYL CPEETETHSP
361 MKTNNQDHNG NIPKPASKDL ASTNSGHSDC SVSMGNLSPL ASPANLLQQT EDQIPSNLEG
421 PFVNLLPPLL QEDYLLSLGE EEGISDLFDA YDLEKLPLVE DFMCSLocalizationUniProt · AlphaFold · HPA
Whether an antibody against E2F3 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.57
- Highest tissue expression
- 19 nTPM
Expression across tissuesHPA
Tissue
- bone marrow: 19 nTPM
- lymph node: 10 nTPM
- skeletal muscle: 9.4 nTPM
- appendix: 9.2 nTPM
- tonsil: 8.9 nTPM
- tongue: 8.7 nTPM
Single-cell type
- neutrophils: 917 nCPM
- neutrophil progenitors: 366 nCPM
- monocyte progenitors: 244 nCPM
- megakaryocyte-erythroid progenitors: 195 nCPM
- megakaryocyte progenitors: 193 nCPM
- platelets: 170 nCPM
Immune cell
- neutrophil: 7.2 nTPM
- basophil: 5.5 nTPM
- NK-cell: 3.4 nTPM
- myeloid DC: 2.6 nTPM
- memory CD8 T-cell: 2.4 nTPM
- classical monocyte: 2.3 nTPM
Brain region
- hippocampal formation: 13 nTPM
- cerebral cortex: 11 nTPM
- hypothalamus: 11 nTPM
- basal ganglia: 9.9 nTPM
- amygdala: 9.2 nTPM
- midbrain: 9.2 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.35
- gnomAD pLI
- 0.95
- gnomAD missense Z
- 1.59
- DepMap mean gene effect
- -0.22
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 9% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- G1/S transition of mitotic cell cycle
- negative regulation of fat cell proliferation
- positive regulation of cell population proliferation
- positive regulation of transcription by RNA polymerase II
- positive regulation of vascular associated smooth muscle cell apoptotic process
- protein import into nucleus
- regulation of transcription by RNA polymerase II
- transcription initiation at RNA polymerase II promoter
Molecular functions
- cis-regulatory region sequence-specific DNA binding
- DNA-binding transcription activator activity
- DNA-binding transcription activator activity, RNA polymerase II-specific
- DNA-binding transcription factor activity
- DNA-binding transcription factor activity, RNA polymerase II-specific
- protein dimerization activity
- RNA polymerase II cis-regulatory region sequence-specific DNA binding
- sequence-specific DNA binding
- sequence-specific double-stranded DNA binding
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of E2F3 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads E2F3 as an antibody target. Whether an autoantibody or antibody against E2F3 could matter depends on whether native E2F3 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
E2F3 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label E2F3 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...